Occurrence of a RAGE-Mediated Inflammatory Response in Human Fetal Membranes.

RAGE alarmins fetal membranes rupture of fetal membranes sterile inflammation

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2020
Historique:
received: 04 03 2020
accepted: 11 05 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 17 7 2020
Statut: epublish

Résumé

Sterile inflammation has been shown to play a key role in the rupture of the fetal membranes (FMs). Moreover, an early and exacerbated runaway inflammation can evolve into a preterm premature rupture of membranes and lead to potential preterm birth. In this context, we investigated the receptor for advanced glycation end products (RAGE), an axis implied in physiological sterile inflammation, in conjunction with two major ligands: AGEs and High-Mobility Group Box 1 (HMGB1). Our first objective was to determine the spatiotemporal expression profiles of the different actors of the RAGE-signaling axis in human FMs, including its intracellular adaptors Diaphanous-1 and Myd88. Our second goal was to evaluate the functionality of RAGE signaling in terms of FMs inflammation. The presence of the actors (RAGE, HMGB1, Myd88, and Diaphanous-1) at the mRNA level was investigated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in the human amnion and choriodecidua at the three trimesters and at term. Measurements were conducted at two distinct zones: the zone of intact morphology (ZIM) and the zone of altered morphology (ZAM). Then, proteins were quantified using Western blot analysis, and their localization was evaluated by immunofluorescence in term tissues. In addition, pro-inflammatory cytokine secretion was quantified using a Multiplex assay after the treatment of amnion and choriodecidua explants with two RAGE ligands (AGEs and HMGB1) in the absence or presence of a RAGE inhibitor (SAGEs). The FMs expressed the RAGE-signaling actors throughout pregnancy. At term, RNA and protein overexpression of the RAGE, HMGB1, and Diaphanous-1 were found in the amnion when compared to the choriodecidua, and the RAGE was overexpressed in the ZAM when compared to the ZIM. The two RAGE ligands (AGEs and HMGB1) induced differential cytokine production (IL1β and TNFα) in the amnion and choriodecidua. Considered together, these results indicate that RAGE signaling is present and functional in human FMs. Our work opens the way to a better understanding of FMs weakening dependent on a RAGE-based sterile inflammation.

Identifiants

pubmed: 32670078
doi: 10.3389/fphys.2020.00581
pmc: PMC7330021
doi:

Types de publication

Journal Article

Langues

eng

Pagination

581

Informations de copyright

Copyright © 2020 Choltus, Lavergne, Belville, Gallot, Minet-Quinard, Durif, Blanchon and Sapin.

Références

Lancet. 1980 Jan 26;1(8161):192-4
pubmed: 6101643
Prenat Diagn. 2012 Sep;32(9):840-5
pubmed: 22711432
Reproduction. 2016 Dec;152(6):R277-R292
pubmed: 27679863
BJOG. 2006 Dec;113 Suppl 3:17-42
pubmed: 17206962
Autophagy. 2012 Jun;8(6):989-91
pubmed: 22722139
Ann Pharm Fr. 2014 Nov;72(6):400-8
pubmed: 25438650
J Biol Chem. 1992 Jul 25;267(21):14998-5004
pubmed: 1378843
Am J Obstet Gynecol. 2004 Nov;191(5):1678-87
pubmed: 15547542
Am J Reprod Immunol. 2014 Nov;72(5):458-74
pubmed: 25078709
J Matern Fetal Neonatal Med. 2015 Aug;28(12):1394-409
pubmed: 25190175
J Perinat Med. 2008;36(5):399-404
pubmed: 18771410
Eye (Lond). 1993;7 ( Pt 2):230-7
pubmed: 7607341
Taiwan J Obstet Gynecol. 2018 Apr;57(2):211-216
pubmed: 29673663
Biol Reprod. 2016 Dec;95(6):130
pubmed: 27806943
Semin Perinatol. 2017 Nov;41(7):409-419
pubmed: 28807394
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Placenta. 2014 Dec;35(12):1049-56
pubmed: 25454284
Biol Reprod. 2012 Feb 29;86(2):48
pubmed: 22053096
Placenta. 2007 Feb-Mar;28(2-3):161-9
pubmed: 16513165
Prim Care Update Ob Gyns. 1998 Jul 1;5(4):181
pubmed: 10838337
Cytokine. 2016 May;81:82-7
pubmed: 26954343
Obstet Gynecol Clin North Am. 2020 Mar;47(1):147-162
pubmed: 32008665
J Biol Chem. 2010 Jul 23;285(30):23233-40
pubmed: 20507991
Am J Reprod Immunol. 2013 Jan;69(1):33-40
pubmed: 22967004
Placenta. 2016 Aug;44:1-5
pubmed: 27452431
Free Radic Res. 2013 Aug;47 Suppl 1:70-80
pubmed: 23796030
Placenta. 2014 Feb;35 Suppl:S64-8
pubmed: 24388429
Immunology. 2007 Nov;122(3):430-7
pubmed: 17617154
Am J Reprod Immunol. 2014 Oct;72(4):422-34
pubmed: 24867252
Annu Rev Med. 2018 Jan 29;69:349-364
pubmed: 29106804
J Endocrinol. 2007 May;193(2):269-77
pubmed: 17470518
J Matern Fetal Neonatal Med. 2019 Apr 30;:1-7
pubmed: 31039652
Am J Obstet Gynecol. 1980 Jan 1;136(1):92-6
pubmed: 7352493
Biomed Res Int. 2015;2015:568042
pubmed: 26413536
N Engl J Med. 1998 Mar 5;338(10):663-70
pubmed: 9486996
Am J Reprod Immunol. 2015 Jan;73(1):36-55
pubmed: 25283845
PLoS One. 2014 Dec 03;9(12):e113799
pubmed: 25469638
J Matern Fetal Neonatal Med. 2019 Aug;32(16):2758-2762
pubmed: 29506420
Am J Perinatol. 2013 Nov;30(10):821-6
pubmed: 23329562
Anal Biochem. 2013 Sep 15;440(2):186-8
pubmed: 23747530
J Biol Chem. 2002 Feb 22;277(8):6296-302
pubmed: 11741975
PLoS One. 2011;6(8):e23132
pubmed: 21829704
Placenta. 2019 Apr;79:40-45
pubmed: 30454905
Placenta. 2006 Nov-Dec;27(11-12):1037-51
pubmed: 16516962
Neurosci Biobehav Rev. 2016 Mar;62:48-55
pubmed: 26724598
Gynecol Obstet Fertil Senol. 2018 Dec;46(12):1004-1021
pubmed: 30385352
PLoS One. 2011 Feb 09;6(2):e16658
pubmed: 21347371
J Clin Med. 2019 Nov 15;8(11):
pubmed: 31731659
Can J Physiol Pharmacol. 2019 Mar;97(3):206-212
pubmed: 30485131
Circ Res. 2012 May 11;110(10):1279-93
pubmed: 22511750
Am J Pathol. 1993 Dec;143(6):1699-712
pubmed: 8256857
J Leukoc Biol. 2013 Jul;94(1):55-68
pubmed: 23543766
J Biol Chem. 2008 Dec 5;283(49):34457-68
pubmed: 18922799
J Matern Fetal Neonatal Med. 2011 Dec;24(12):1444-55
pubmed: 21958433
J Perinat Med. 2008;36(5):388-98
pubmed: 18593373

Auteurs

Héléna Choltus (H)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.

Marilyne Lavergne (M)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.

Corinne Belville (C)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.

Denis Gallot (D)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
CHU de Clermont-Ferrand, Obstetrics and Gynecology Department, Clermont-Ferrand, France.

Régine Minet-Quinard (R)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
CHU de Clermont-Ferrand, Biochemistry and Molecular Genetic Department, Clermont-Ferrand, France.

Julie Durif (J)

CHU de Clermont-Ferrand, Biochemistry and Molecular Genetic Department, Clermont-Ferrand, France.

Loïc Blanchon (L)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.

Vincent Sapin (V)

CNRS, INSERM, GReD, Université Clermont Auvergne, Clermont-Ferrand, France.
CHU de Clermont-Ferrand, Biochemistry and Molecular Genetic Department, Clermont-Ferrand, France.

Classifications MeSH